Literature DB >> 15606609

CD26 (dipeptidyl-peptidase IV)-dependent recruitment of T cells in a rat asthma model.

C Kruschinski1, T Skripuletz, S Bedoui, T Tschernig, R Pabst, C Nassenstein, A Braun, S von Hörsten.   

Abstract

CD26 truncates several chemokines as well as neuropeptides and influences immune responses via modulation of cell adhesion and T cell activation, suggesting an involvement of CD26 in asthmatic and airway inflammation. Therefore, Fischer 344 (F344), Brown Norway (BN) and Lewis (LEW) rat strains, which differ in their CD26-like enzymatic activity, were compared using an asthma model. Additionally, two CD26-deficient mutant F344 rat substrains were included and compared to the wild-type F344 substrain. Immunization was performed twice with ovalbumin (OVA), and 2 weeks later the rats were challenged with OVA intratracheally Flow cytometry (FACS) analysis of different leucocyte subsets as well as enzyme-linked immunosorbent assay (ELISA) for IgE levels in the blood and bronchoalveolar lavage (BAL) were performed 24 h after challenge. LEW rats with the lowest CD26 activity among the rat strains investigated here displayed significantly reduced CD4+ T cell numbers in the BAL compared to wild-type F344 and BN rats. Moreover, in asthma, the ratio of CD26+ to CD26- T cell receptor (TCR)-positive cells increased significantly in F344 and LEW but not BN rats. Most intriguingly, in both CD26-deficient F344 rat substrains the number of CD4+ T lymphocytes was markedly reduced compared to wild-type F344. The decrease in T cell recruitment observed in the CD26-deficient rats was associated with significantly reduced OVA-specific IgE-titres. This is the first report to show a remarkably reduced T cell recruitment in rat strains that either lack or exhibit reduced CD26-like enzymatic activity, suggesting a role for CD26 in the pathogenesis of asthma via T cell-dependent processes such as antibody production.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15606609      PMCID: PMC1809259          DOI: 10.1111/j.1365-2249.2005.02666.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  35 in total

Review 1.  CD26, let it cut or cut it down.

Authors:  I De Meester; S Korom; J Van Damme; S Scharpé
Journal:  Immunol Today       Date:  1999-08

Review 2.  T cells and chronic asthma.

Authors:  O M Kon; A B Kay
Journal:  Int Arch Allergy Immunol       Date:  1999 Feb-Apr       Impact factor: 2.749

3.  In vitro bronchial responsiveness in two highly inbred rat strains.

Authors:  C G Wang; J J Almirall; C S Dolman; R J Dandurand; D H Eidelman
Journal:  J Appl Physiol (1985)       Date:  1997-05

Review 4.  The structure and function of CD26 in the T-cell immune response.

Authors:  C Morimoto; S F Schlossman
Journal:  Immunol Rev       Date:  1998-02       Impact factor: 12.988

Review 5.  Dipeptidyl-peptidase IV/CD26 on T cells: analysis of an alternative T-cell activation pathway.

Authors:  A von Bonin; J Hühn; B Fleischer
Journal:  Immunol Rev       Date:  1998-02       Impact factor: 12.988

6.  Asthma: an inflammatory mediator soup.

Authors:  U S Björnsdottir; D M Cypcar
Journal:  Allergy       Date:  1999       Impact factor: 13.146

7.  Kinetics and quantitation of eosinophil and neutrophil recruitment to allergic lung inflammation in a brown Norway rat model.

Authors:  T Schneider; D van Velzen; R Moqbel; A C Issekutz
Journal:  Am J Respir Cell Mol Biol       Date:  1997-12       Impact factor: 6.914

8.  Eotaxin induces a rapid release of eosinophils and their progenitors from the bone marrow.

Authors:  R T Palframan; P D Collins; T J Williams; S M Rankin
Journal:  Blood       Date:  1998-04-01       Impact factor: 22.113

9.  Autocrine interaction between IL-5 and IL-1beta mediates altered responsiveness of atopic asthmatic sensitized airway smooth muscle.

Authors:  H Hakonarson; N Maskeri; C Carter; S Chuang; M M Grunstein
Journal:  J Clin Invest       Date:  1999-09       Impact factor: 14.808

10.  An active-site mutation (Gly633-->Arg) of dipeptidyl peptidase IV causes its retention and rapid degradation in the endoplasmic reticulum.

Authors:  E Tsuji; Y Misumi; T Fujiwara; N Takami; S Ogata; Y Ikehara
Journal:  Biochemistry       Date:  1992-12-01       Impact factor: 3.162

View more
  24 in total

1.  CD26 T cells in the pathogenesis of asthma.

Authors:  K Ohnuma; T Yamochi; O Hosono; C Morimoto
Journal:  Clin Exp Immunol       Date:  2005-01       Impact factor: 4.330

Review 2.  Cut to the chase: a review of CD26/dipeptidyl peptidase-4's (DPP4) entanglement in the immune system.

Authors:  C Klemann; L Wagner; M Stephan; S von Hörsten
Journal:  Clin Exp Immunol       Date:  2016-05-13       Impact factor: 4.330

3.  Sitagliptin exerts anti-inflammatory and anti-allergic effects in ovalbumin-induced murine model of allergic airway disease.

Authors:  Manar A Nader; Mohammed S El-Awady; Asem A Shalaby; Dina S El-Agamy
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-06-26       Impact factor: 3.000

4.  IL-13 and epidermal growth factor receptor have critical but distinct roles in epithelial cell mucin production.

Authors:  Guohua Zhen; Sung Woo Park; Louis T Nguyenvu; Madeleine W Rodriguez; Rebecca Barbeau; Agnes C Paquet; David J Erle
Journal:  Am J Respir Cell Mol Biol       Date:  2006-09-15       Impact factor: 6.914

5.  CD26/dipeptidyl peptidase 4-deficiency alters thymic emigration patterns and leukcocyte subsets in F344-rats age-dependently.

Authors:  C Klemann; J Schade; R Pabst; S Leitner; J Stiller; S von Hörsten; M Stephan
Journal:  Clin Exp Immunol       Date:  2008-12-01       Impact factor: 4.330

6.  Regulation of expression and function of dipeptidyl peptidase 4 (DP4), DP8/9, and DP10 in allergic responses of the lung in rats.

Authors:  Jutta Schade; Michael Stephan; Andreas Schmiedl; Leona Wagner; André J Niestroj; Hans-Ulrich Demuth; Nadine Frerker; Christian Klemann; Kerstin A Raber; Reinhard Pabst; Stephan von Hörsten
Journal:  J Histochem Cytochem       Date:  2007-10-29       Impact factor: 2.479

7.  Airway-specific recruitment of T cells is reduced in a CD26-deficient F344 rat substrain.

Authors:  J Schade; A Schmiedl; A Kehlen; T Z Veres; M Stephan; R Pabst; S von Hörsten
Journal:  Clin Exp Immunol       Date:  2009-10       Impact factor: 4.330

8.  Blocking KV1.3 channels inhibits Th2 lymphocyte function and treats a rat model of asthma.

Authors:  Shyny Koshy; Redwan Huq; Mark R Tanner; Mustafa A Atik; Paul C Porter; Fatima S Khan; Michael W Pennington; Nicola A Hanania; David B Corry; Christine Beeton
Journal:  J Biol Chem       Date:  2014-03-18       Impact factor: 5.157

9.  Soluble CD26 is inversely Associated with Disease Severity in Patients with Chronic Eosinophilic Pneumonia.

Authors:  Osamu Matsuno; Eishi Miyazaki; Shinichi Nureki; Takuya Ueno; Masaru Ando; Toshihide Kumamoto
Journal:  Biomark Insights       Date:  2007-02-07

10.  Genetic ablation or pharmacological blockade of dipeptidyl peptidase IV does not impact T cell-dependent immune responses.

Authors:  Kalpit A Vora; Gene Porter; Roche Peng; Yan Cui; Kellyann Pryor; George Eiermann; Dennis M Zaller
Journal:  BMC Immunol       Date:  2009-04-09       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.